The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Polycystic Ovarian Syndrome: Evidence that Flutamide Restores Sensitivity of the Gonadotropin-Releasing Hormone Pulse Generator to Inhibition by Estradiol and Progesterone1
Abstract
Polycystic ovarian syndrome (PCOS) is a complex disorder with multiple abnormalities, including hyperandrogenism, ovulatory dysfunction, and altered gonadotropin secretion. The majority of patients have elevated LH levels in plasma and a persistent rapid frequency of LH (GnRH) pulse secretion, the mechanisms of which are unclear. Earlier work has suggested that the sensitivity of the GnRH pulse generator to inhibition by ovarian steroids is impaired. We performed a study to determine whether antiandrogen therapy with flutamide could enhance feedback inhibition by estradiol (E2) and progesterone (P) in women with PCOS. Ten anovulatory women with PCOS and nine normal controls (days 8-10 of the cycle) were studied on three occasions. During each admission, LH and FSH were determined every 10 min and E2, P, and testosterone (T) every 2 h for 13 h. After 12 h, GnRH (25 ng/kg) was given iv. After the first admission, patients were started on flutamide (250 mg twice daily), which was continued for the entire study. The second admission occurred on days 8-10 of the next menstrual cycle for normal controls and on study day 28 for PCOS patients. Subjects were then given E2 transdermally (mean plasma E2, 106+/-18 pg/mL) and P by vaginal suppository to obtain varied plasma concentrations of P (mean P, 4.4+/-0.5 ng/mL; range, 0.6-9.0 ng/mL), and a third study was performed 7 days later. At baseline women with PCOS had higher LH pulse amplitude, response to GnRH, T, androstenedione, and insulin and lower sex hormone-binding globulin concentrations (P < 0.05). Most hormonal parameters were not altered by 4 weeks of flutamide, except T in controls and E2 and FSH in PCOS patients, which were lower. Of note, flutamide alone had no effect on LH pulse frequency or amplitude, mean plasma LH, or LH responsiveness to exogenous GnRH. After the addition of E2 and P for 7 days, both PCOS patients and normal controls had similar reductions in LH pulse frequency (4.0+/-0.7 and 5.8+/-0.7 pulses/12 h, respectively). This contrasts with our earlier results in the absence of flutamide, where a plasma P level of less than 10 ng/mL had minimal effects on LH pulse frequency in women with PCOS, but was effective in controls. These results suggest that although the elevated LH pulse frequency in PCOS may in part reflect impaired sensitivity to E2 and P, continuing actions of hyperandrogenemia are important for sustaining the abnormal hypothalamic sensitivity to feedback inhibition by ovarian steroids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Amenorrhea associated with bilateral polycystic ovaries
Stein, I. F., & Leventhal, M. L. (1935) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30642-6 · Cited by 2,121
Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.
Adams, J., Polson, D. W., & Franks, S. (1986) · BMJ · doi:10.1136/bmj.293.6543.355 · Cited by 981
Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection
Veldhuis, J. D., & Johnson, M. L. (1986) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1986.250.4.e486 · Cited by 861
Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
Rebar, R., Judd, H. L., Yen, S. S., Rakoff, J., Vandenberg, G., & Naftolin, F. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108400 · Cited by 622
Veldhuis, J. D., Carlson, M. L., & Johnson, M. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7686 · Cited by 549
EHRMAN, D. A., BARNES, R. B., & ROSENFIELD, R. L. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-322 · Cited by 502
Taylor, A. E., McCourt, B., Martin, K. A., Anderson, E. J., Adams, J. M., Schoenfeld, D., & Hall, J. E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4105 · Cited by 494
FILICORI, M., SANTORO, N., MERRIAM, G. R., & CROWLEY, W. F. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-6-1136 · Cited by 489
WALDSTREICHER, J., SANTORO, N. F., HALL, J. E., FILICORI, M., & CROWLEY, W. F. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-1-165 · Cited by 407
Ehrmann, D. A. (1995) · Endocrine Reviews · doi:10.1210/er.16.3.322 · Cited by 401
YEN, S. S. C., VELA, P., & RANKIN, J. (1970) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-30-4-435 · Cited by 389
Progesterone Modulation of Pulsatile Luteinizing Hormone Secretion in Normal Women*
SOULES, M. R., STEINER, R. A., CLIFTON, D. K., COHEN, N. L., AKSEL, S., & BREMNER, W. J. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-58-2-378 · Cited by 319
Barnes, R. B., Rosenfield, R. L., Ehrmann, D. A., Cara, J. F., Cuttler, L., Levitsky, L. L., & Rosenthal, I. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962325 · Cited by 304
Pastor, C. L., Griffin-Korf, M. L., Aloi, J. A., Evans, W. S., & Marshall, J. C. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4604 · Cited by 263
Self-citationChang, R. J., Laufer, L. R., Meldrum, D. R., Defazio, J., Lu, J. K. H., Vale, W. W., Rivier, J. E., & Judd, H. L. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-56-5-897 · Cited by 259
REAME, N., SAUDER, S. E., KELCH, R. P., & MARSHALL, J. C. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-2-328 · Cited by 258
Self-citationTHE EPIDEMIOLOGY OF POLYCYSTIC OVARY SYNDROME
Solomon, C. G. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70069-4 · Cited by 226
Gonadotropin-Releasing Hormone: Role of Pulsatile Secretion in the Regulation of Reproduction
Flier, J. S., Underhill, L. H., Marshall, J. C., & Kelch, R. P. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612043152306 · Cited by 216
Self-citationTaylor, A. E. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.7.2248 · Cited by 211
SPINDER, T., SPIJKSTRA, J. J., VAN DEN TWEEL, J. G., BURGER, C. W., VAN KESSEL, H., HOMPES, P. G. A., & GOOREN, L. J. G. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-1-151 · Cited by 208
Hormonal Effects of Flutamide in Young Women with Polycystic Ovary Syndrome
Leo, V. D., Lanzetta, D., D’Antona, D., Marca, A. L., & Morgante, G. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.1.99 · Cited by 192
SERUM STEROIDS AND PITUITARY HORMONES IN FEMALE PUBERTY: A PARTLY LONGITUDINAL STUDY
APTER, D. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb02125.x · Cited by 185
INSULIN ACTION IN THE POLYCYSTIC OVARY SYNDROME
Dunaif, A. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70073-6 · Cited by 182
Apter, D. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.1.119 · Cited by 178
Dumesic, D. A., Abbott, D. H., Eisner, J. R., & Goy, R. W. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81873-0 · Cited by 171
Pulsatile Secretion of Luteinizing Hormone in Children*
JAKACKI, R. I., KELCH, R. P., SAUDER, S. E., LLOYD, J. S., HOPWOOD, N. J., & MARSHALL, J. C. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-3-453 · Cited by 171
Self-citationCirculating Luteinizing Hormone Pulse Frequency in Women with Polycystic Ovary Syndrome *
Kazer, R. R., Kessel, B., & Yen, S. S. C. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-2-233 · Cited by 157
Apter, D. L., & Vihko, R. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-4-970 · Cited by 148
Robinson, J. E., Forsdike, R. A., & Taylor, J. A. (1999) · Endocrinology · doi:10.1210/endo.140.12.7205 · Cited by 147
NEUROENDOCRINE ASPECTS OF POLYCYSTIC OVARY SYNDROME
Marshall, J. C., & Eagleson, C. A. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70071-2 · Cited by 138
Self-citationDaniels, T. L., & Berga, S. L. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4402 · Cited by 137
Nippoldt, T. B., Reame, N. E., Kelch, R. P., & Marshall, J. C. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-1-67 · Cited by 121
Self-citationPoretsky, L., & Piper, B. (1994) · PubMed · Cited by 102
Insulin and the Polycystic Ovary Syndrome
Utiger, R. D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350909 · Cited by 98
Venturoli, S. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.4.1548348 · Cited by 93
Increased luteinizing hormone and alpha-subunit secretion in women with hyperandrogenic anovulation
Berga, S. L., Guzick, D. S., & Winters, S. J. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.4.7691863 · Cited by 83
Moghetti, P., Castello, R., Negri, C., Tosi, F., Magnani, C. M., Fontanarosa, M. C., Armanini, D., & Muggeo, M. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57785-1 · Cited by 81
Franks, S. (2005) · Medicine · doi:10.1383/medc.2005.33.11.38 · Cited by 80
Venturoli, S., Porcu, E., Fabbri, R., MAGRINI, O., Paradisi, R., Pallotti, G., Gammi, L., & Flamigni, C. (1987) · Fertility and Sterility · doi:10.1016/s0015-0282(16)59294-2 · Cited by 76
Couzinet, B., Pholséna, M., Young, J., et al. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb01768.x · Cited by 71
Acute modulation of the hypothalamic-pituitary axis by intravenous testosterone in normal women
Serafini, P. C., Silva, P. D., Paulson, R. J., Elkind-Hirsch, K. E., Hernandez, M., & Løbo, R. A. (1986) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(86)90161-4 · Cited by 68
Sir‐Petermann, T., Rabenbauer, B., & Wildt, L. (1993) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a137938 · Cited by 20
The Use of Antiandrogen Flutamide in the Treatment of Hirsutism.
Gedik, V. T., Kamel, N., Uysal, A. R., et al. (1994) · Endocrine Journal · doi:10.1507/endocrj.41.573 · Cited by 15
Barkan, A. L., Cassorla, F. G., Loriaux, D. L., Kelch, R. P., & Marshall, J. C. (1985) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198503000-00015 · Cited by 14
Self-citationFrank, S. J. (1995) · Cited by 13
Cited by
Ehrmann, D. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041536 · Cited by 1,881
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020
Self-citationUpdate on PCOS: consequences, challenges, and guiding treatment
Hoeger, K. M., Dokras, A., & Piltonen, T. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa839 · Cited by 610
Metadata
- Authors
- Eagleson, C. A., Gingrich, M. B., Pastor, C. L., Arora, T. K., Burt, C. M., Evans, W. S., & Marshall, J. C.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2000-11
- Volume
- 85
- Issue
- 11
- Pages
- 4047-4052
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2039410885
- Cited by
- 345
- References
- 46
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.